Results 171 to 180 of about 19,292 (214)

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

open access: yesTransplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez   +16 more
wiley   +1 more source

[Epidemiological characteristics of febrile seizure among children under 6 years old in Ningbo City from 2015 to 2021]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Liu G   +10 more
europepmc   +1 more source

Clinical performance and limitations of a vital sign‐based electronic automatic notification system for suspected transfusion reactions: A 6‐year experience

open access: yesTransfusion, EarlyView.
Abstract Background Automated surveillance systems such as the electronic automatic notification system (EANS) have been introduced to improve recognition of adverse transfusion reactions (ATRs), but their long‐term sustainability and operational limitations remain incompletely defined. Study Design and Methods We conducted a 6‐year retrospective study
Young Ae Lim, Chorong Park, Jin Kim
wiley   +1 more source

A PIGG congenital disorder of glycosylation (PIGG‐CDG) variant associated with an Emm− red blood cell phenotype in a pediatric patient

open access: yesTransfusion, EarlyView.
Abstract Background The high‐prevalence Emm antigen is an epitope on the GPI (glycosylphosphatidylinositol) glycolipid backbone, which anchors proteins to the cell surface. Inherited loss‐of‐function of PIGG (or PIGO) results in the rare Emm− red cell (RBC) phenotype and is associated with congenital disorders of glycosylation (CDG).
Alastair Murray   +8 more
wiley   +1 more source

Prospective multi‐centre haemovigilance of amotosalen and ultraviolet A‐treated platelets and plasma in routine clinical use

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Amotosalen/ultraviolet A light (A/UVA) pathogen‐reduced platelets and plasma have been approved for clinical use in Europe since 2003 and 2006, respectively. Cross‐sectional safety haemovigilance (HV) studies have been conducted in 29 hospitals in 15 European countries since 2003. This report describes the most recent
Magdalena Łętowska   +14 more
wiley   +1 more source

Predicting factors for acute encephalopathy in febrile seizure children with SARS-CoV-2 omicron variant: a retrospective study. [PDF]

open access: yesBMC Pediatr
Tang CM   +11 more
europepmc   +1 more source

Acute Neurological Events in Children With Hemoglobin SC Disease: A Multicenter Retrospective Study

open access: yesPediatric Blood &Cancer, Volume 73, Issue 11, November 2026.
ABSTRACT Introduction Neurological manifestations in children with hemoglobin SC (HbSC) disease remain insufficiently characterized, particularly regarding acute events. The aim of this study was to describe the spectrum and frequency of acute neurological events in a multicenter cohort of children with HbSC disease.
Célia Paulmin   +11 more
wiley   +1 more source

Refining Domain‐Based Prognostication in DNM1 Encephalopathy: A Mild Phenotype Associated With a GTPase Domain Variant

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 11, Page 2558-2561, November 2026.
ABSTRACT DNM1 encephalopathy is a rare autosomal dominant genetic condition characterized by a range of neurological and developmental manifestations. The typical phenotype is severe, including profound intellectual disability, treatment‐resistant epilepsy, ataxia, and structural brain abnormalities. However, milder presentations have increasingly been
Caroline Crain   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy